# NHS Pharmaceuticals 2017\_2

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Please see list of awarded suppliers \(including SME status\) at t
- Award value: £22,630,855
- Tender value: £22,630,855
- Award date: 19 April 2018
- Published: 21 May 2018
- Contract start: 1 August 2018
- Contract end: 31 January 2020
- Stage: awarded
- Procurement category: goods
- Notice ID: 5f0d541f-87ab-45de-a00f-2df46a14eb23-217271
- OCID: ocds-b5fd17-d06123ce-f0d7-40dd-8785-4cccd9828760

## Description

NHS Pharmaceuticals 2017\_2\. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months\. Potential periods of call-offs under the framework agreement: CESW regions: 1\.8\.2018 to 28\.2\.2019 \(7 months\)\. NWLN regions: 1\.8\.2018 to 31\.7\.2019 \(12 months\)\. LSNE regions: 1\.8\.2018 to 31\.1\.2020 \(18 months\)\. Products on the framework include \(but are not necessarily limited to\): Abacavir, Abiraterone, Anidulafungin, Atovaquone, Bosentan, Ciclesonide, Drospirenone/Ethinylestradiol, Enfurvitide, Ethinylestradiol/Norelgestromin, Exenatide, Ezetimibe, Iloprost, Ivabradine, Mycophenolic acid, Nitisinone, Olopatadine, Oseltamivir, Parecoxib, Pegfilgrastim, Pegvisomant, Pregabalin, Tadalafil, Tenofovir, Tigecycline, Valproic acid, Velaglucerase\. Details of regions, presentation sizes and volumes are within the tender document set\.

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [NHS National Pharmaceuticals Transition 2020\_2](/contracts/ocds-b5fd17-7794ddce-62fc-4be4-bc35-be7b9eb80c66): NHS England
- [NHS National Generic Pharmaceuticals Interim 1 2020](/contracts/ocds-b5fd17-a01f42cd-4c5e-443f-823e-e9082c06fcbf): NHS England
- [NHS National Pharmaceuticals Transition 2020\_1](/contracts/ocds-b5fd17-429f0eca-56a9-4f06-a5a9-2c4cc7c8a1c4): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/5f0d541f-87ab-45de-a00f-2df46a14eb23-217271)